Raymond James Financial
IFRX icon

Raymond James Financial’s InflaRx IFRX Stock Holding History

Raymond James Financial’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Sell
377,163
-18,640
-5% -$35K ﹤0.01% 4123
2026
Q1 		$354K Buy
395,803
+3,786
+1% +$3.58K ﹤0.01% 4577
2025
Q4 		$396K Sell
392,017
-65,882
-14% -$81.8K ﹤0.01% 4417
2025
Q3 		$614K Sell
457,899
-69,267
-13% -$73.5K ﹤0.01% 3994
2025
Q2 		$416K Sell
527,166
-105,038
-17% -$124K ﹤0.01% 4113
2025
Q1 		$645K Sell
632,204
-5,888
-0.9% -$11.1K ﹤0.01% 3771
2024
Q4 		$1.58M Buy
+638,092
New +$1.23M ﹤0.01% 3139

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Raymond James Financial's IFRX Position: Q2 2026 in Review

Raymond James Financial reduced its InflaRx (IFRX) stake by 4.7% in Q2 2026, selling an estimated $35K and leaving 377,163 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #4123.

Raymond James Financial first reported a position in IFRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.58M in Q4 2024. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Raymond James Financial held 377,163 shares of InflaRx worth $845K as of Q2 2026.
  • Raymond James Financial sold 18,640 InflaRx shares in Q2 2026, an estimated $35K.
  • InflaRx made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4123 holding.
  • Raymond James Financial first reported a position in InflaRx in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's InflaRx position peaked at $1.58M in Q4 2024.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.